Could Guillain–Barré syndrome be triggered by COVID‐19 vaccination?
<p></p><div> <p>Due to SARS-COV-2 (COVID-19) pandemic and its catastrophic impact on society, the FDA granted emergency use authorization for some vaccines. Possible rare side effects could not have been observed in this relatively short period. We are reporting an elderly la...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , |
| منشور في: |
2023
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513565685186560 |
|---|---|
| author | Maya Aldeeb (14777215) |
| author2 | Lina Okar (14777164) Safa S. Mahmud (14777899) Gholam A. Adeli (14777902) |
| author2_role | author author author |
| author_facet | Maya Aldeeb (14777215) Lina Okar (14777164) Safa S. Mahmud (14777899) Gholam A. Adeli (14777902) |
| author_role | author |
| dc.creator.none.fl_str_mv | Maya Aldeeb (14777215) Lina Okar (14777164) Safa S. Mahmud (14777899) Gholam A. Adeli (14777902) |
| dc.date.none.fl_str_mv | 2023-03-16T06:21:07Z |
| dc.identifier.none.fl_str_mv | 10.1002/ccr3.5237 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/Could_Guillain_Barr_syndrome_be_triggered_by_COVID_19_vaccination_/22257883 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biomedical and clinical sciences Cardiovascular medicine and haematology General Medicine |
| dc.title.none.fl_str_mv | Could Guillain–Barré syndrome be triggered by COVID‐19 vaccination? |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <p></p><div> <p>Due to SARS-COV-2 (COVID-19) pandemic and its catastrophic impact on society, the FDA granted emergency use authorization for some vaccines. Possible rare side effects could not have been observed in this relatively short period. We are reporting an elderly lady with multiple comorbidities who presented with progressive lower limb weakness that started seven days after receiving the first dose of the COVID-19 vaccine. The electrodiagnostic study showed demyelinating polyneuropathy with secondary axonal degeneration consistent with Guillain–Barré syndrome. We ruled out other possible causes for GBS, suggesting a postvaccine nature for her presentation. The patient received intravenous immunoglobulin (IVIG) for five days and gradually improved, which supports our initial diagnosis.</p> </div><p></p><h2>Other Information</h2> <p> Published in: Clinical Case Reports<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1002/ccr3.5237" target="_blank">http://dx.doi.org/10.1002/ccr3.5237</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_1d4ecdb62ed78978f694e1016b9f0265 |
| identifier_str_mv | 10.1002/ccr3.5237 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/22257883 |
| publishDate | 2023 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Could Guillain–Barré syndrome be triggered by COVID‐19 vaccination?Maya Aldeeb (14777215)Lina Okar (14777164)Safa S. Mahmud (14777899)Gholam A. Adeli (14777902)Biomedical and clinical sciencesCardiovascular medicine and haematologyGeneral Medicine<p></p><div> <p>Due to SARS-COV-2 (COVID-19) pandemic and its catastrophic impact on society, the FDA granted emergency use authorization for some vaccines. Possible rare side effects could not have been observed in this relatively short period. We are reporting an elderly lady with multiple comorbidities who presented with progressive lower limb weakness that started seven days after receiving the first dose of the COVID-19 vaccine. The electrodiagnostic study showed demyelinating polyneuropathy with secondary axonal degeneration consistent with Guillain–Barré syndrome. We ruled out other possible causes for GBS, suggesting a postvaccine nature for her presentation. The patient received intravenous immunoglobulin (IVIG) for five days and gradually improved, which supports our initial diagnosis.</p> </div><p></p><h2>Other Information</h2> <p> Published in: Clinical Case Reports<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1002/ccr3.5237" target="_blank">http://dx.doi.org/10.1002/ccr3.5237</a></p>2023-03-16T06:21:07ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1002/ccr3.5237https://figshare.com/articles/journal_contribution/Could_Guillain_Barr_syndrome_be_triggered_by_COVID_19_vaccination_/22257883CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/222578832023-03-16T06:21:07Z |
| spellingShingle | Could Guillain–Barré syndrome be triggered by COVID‐19 vaccination? Maya Aldeeb (14777215) Biomedical and clinical sciences Cardiovascular medicine and haematology General Medicine |
| status_str | publishedVersion |
| title | Could Guillain–Barré syndrome be triggered by COVID‐19 vaccination? |
| title_full | Could Guillain–Barré syndrome be triggered by COVID‐19 vaccination? |
| title_fullStr | Could Guillain–Barré syndrome be triggered by COVID‐19 vaccination? |
| title_full_unstemmed | Could Guillain–Barré syndrome be triggered by COVID‐19 vaccination? |
| title_short | Could Guillain–Barré syndrome be triggered by COVID‐19 vaccination? |
| title_sort | Could Guillain–Barré syndrome be triggered by COVID‐19 vaccination? |
| topic | Biomedical and clinical sciences Cardiovascular medicine and haematology General Medicine |